2nd Annual Atlanta Breast Cancer Conference
Meeting Host
Bio AscendDescription
Breast cancer care is advancing faster than ever — and on September 19th, the experts driving that progress are coming to Atlanta.
Join us for the 2nd Annual Atlanta Breast Cancer Conference, a pioneering one-day program offering a comprehensive review of the latest treatments for patients with breast cancer. You'll hear directly from thought leaders from across the nation as they unpack the newest updates in available therapies and explore the novel therapeutic options now in development.
When
September 19th, 2026
Where
JW Marriott Atlanta Buckhead
3300 Lenox Rd NE
Atlanta, GA 30326
Additional Information: https://bioascend.com/atlanta-breast-hotel/
This activity is intended for oncologists, hematologists, pathologists, clinical scientists, nurse practitioners, physician assistants, nurses, and pharmacists engaged in the care of patients with breast cancer.
Learning Objectives
- Assess recent clinical trial data evaluating both currently approved and emerging therapies for the treatment of patients with HR+/HER2– breast cancer and its impact on the current standard of care
- Evaluate the safety and efficacy of currently available and potential future treatment options that are being examined in patients with triple-negative breast cancer
- Examine various patient- and disease-related factors that impact the selection of therapy for patients with HER2+ breast cancer in order to individually tailor care for each patient with this malignancy
- Develop strategies that encourage the multidisciplinary care of patients with all subtypes of breast cancer, including the role of the medical oncologist, surgeon, radiation oncologist, nurse, pharmacist, and advanced practitioner, in order to optimize patient outcomes
CME Info:
Partners designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To receive CME credit points, you MUST pass the posttest and complete the evaluation.
Registration
